Goldman Sachs Group Inc Bio Plus Acquisition Corp. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 14, 2024	SELL	$10.27 - $10.44 $62,585 - $63,621	-6,094 Reduced 5.17%	111,757 $1.17 Million
Q1 2023 May 11, 2023	SELL	$10.27 - $10.44 $62,585 - $63,621	-6,094 Reduced 5.17%	111,757 $1.17 Million
Q3 2022 May 14, 2024	SELL	$9.93 - $10.05 $7.02 Million - $7.11 Million	-707,243 Reduced 85.72%	117,851 $1.18 Million
Q3 2022 Nov 10, 2022	SELL	$9.93 - $10.05 $7.02 Million - $7.11 Million	-707,243 Reduced 85.72%	117,851 $0
Q2 2022 May 14, 2024	BUY	$9.88 - $9.97 $8.15 Million - $8.23 Million	825,094 New	825,094 $8.23 Million
Q1 2022 May 16, 2022	BUY	$9.8 - $9.98 $8.09 Million - $8.23 Million	825,094 New	825,094 $8.15 Million

Others Institutions Holding BIOS

# of Institutions

1

Shares Held

66.6K

Call Options Held

0

Put Options Held

0

Telemetry Investments, L.L.C. New York, NY

66.6K
Shares

$0
1.08% of portfolio

About BioPlus Acquisition Corp.

Ticker BIOS
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,560,000

More about BIOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.